Loading...
Warby Parker Inc.
WRBY•NYSE
Healthcare
Medical - Instruments & Supplies
$24.39
$0.04(0.16%)
Warby Parker Inc. (WRBY) Financial Performance & Income Statement Overview
Review Warby Parker Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
15.16%
↑ 15.16%
Operating Income Growth
58.18%
↑ 58.18%
Net Income Growth
67.74%
↑ 67.74%
Operating Cash Flow Growth
61.90%
↑ 61.90%
Operating Margin
-2.83%
↓ 2.83%
Gross Margin
54.79%
↑ 54.79%
Net Profit Margin
-1.79%
↓ 1.79%
ROE
-4.19%
↓ 4.19%
ROIC
-4.02%
↓ 4.02%
Warby Parker Inc. (WRBY) Income Statement & Financial Overview
Review Warby Parker Inc.'s (WRBY) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $190.64M | $192.45M | $188.22M | $200.003M |
| Cost of Revenue | $87.52M | $87.58M | $86.59M | $90.03M |
| Gross Profit | $103.13M | $104.87M | $101.64M | $109.98M |
| Gross Profit Ratio | $0.54 | $0.54 | $0.54 | $0.55 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $112.54M | $111.48M | $110.59M | $115.10M |
| Operating Expenses | $112.54M | $111.48M | $110.59M | $115.10M |
| Total Costs & Expenses | $200.06M | $199.06M | $197.18M | $205.13M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $12.33M | $0.00 | $11.12M | $10.58M |
| EBITDA | $2.92M | -$6.61M | $2.17M | $5.46M |
| EBITDA Ratio | $0.02 | -$0.03 | $0.01 | $0.03 |
| Operating Income | -$9.42M | -$6.61M | -$8.96M | -$5.13M |
| Operating Income Ratio | -$0.05 | -$0.03 | -$0.05 | -$0.03 |
| Other Income/Expenses (Net) | $2.63M | $2.84M | $2.57M | $2.56M |
| Income Before Tax | -$6.78M | -$3.77M | -$6.39M | -$2.57M |
| Income Before Tax Ratio | -$0.04 | -$0.02 | -$0.03 | -$0.01 |
| Income Tax Expense | $93000.00 | $301000.00 | $373000.00 | $108000.00 |
| Net Income | -$6.88M | -$4.07M | -$6.76M | -$2.68M |
| Net Income Ratio | -$0.04 | -$0.02 | -$0.04 | -$0.01 |
| EPS | -$0.06 | -$0.03 | -$0.06 | -$0.02 |
| Diluted EPS | -$0.06 | -$0.03 | -$0.06 | -$0.02 |
| Weighted Avg Shares Outstanding | $121.41M | $120.89M | $120.09M | $119.14M |
| Weighted Avg Shares Outstanding (Diluted) | $121.41M | $120.89M | $120.09M | $119.14M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan